MT 4 McNEIL (Pancreaze 17,500 U amylase / 4,200 U lipase / 10,000 U protease)
Generic Name: pancrelipase
Pill imprint MT 4 McNEIL has been identified as Pancreaze 17,500 U amylase / 4,200 U lipase / 10,000 U protease.
Pancreaze is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancreaze 17,500 U amylase / 4,200 U lipase / 10,000 U protease is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- MT 4 McNEIL
- 17,500 U amylase / 4,200 U lipase / 10,000 U protease
- Yellow / Clear
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Ortho-McNeil-Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium lauryl sulfate
ferric oxide yellow
More about Pancreaze (pancrelipase)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.